⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

TMO

Thermo Fisher Scientific Inc.

Healthcare · Diagnostics & Research

673.82USD

-2.7200 (-0.40%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on TMO.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 673.82
P/E35.8
Dvd Ind Yld0.3%
P/B4.73
P/S5.4
Curr EV/T12M EBITDA30.6
Mkt Cap (USD)249.1B
Curr EV (USD)284.8B
2)

Per Share Data

EPS T12M18.58
DPS1.78
Bk Val Per Sh148.02
Rev/Sh124.89
Cash/Sh16.38
Curr Shares Out369.7M
FCF/Sh19.73
3)

Cash Flow Analysis

P/CF27.6
Curr P/FCF34.0
CF/NI1.3
Dvd P/O9.5%
Cash Gen/Cash Reqd3.8
Csh Dvd Cov13.6
CFO/Sales19.5%
Eff Interest Rate3.5%
4)

Growth Potential

Dil EPS 1Y Gr7.3%
Cap 1Y Gr16.0%
BPS 1Y Gr9.1%
R&D To Sales3.0%
Retention Rate90.5%
Rev 1Y Gr3.9%
FCF 1Y Gr-13.4%
Assets 1Y Gr13.4%
5)

Profitability

EBITDA9.3B
EBIT8.1B
Operating Margin17.6%
Pretax Margin16.5%
Net Margin15.0%
ROA6.5%
ROE13.5%
ROC7.6%
Asset Turnover0.43
6)

Structure

Current Ratio1.55
Quick Ratio1.11
Debt/Assets40.3%
Debt/Com Eq86.7%
Net Debt/EBITDA4.47
Tot Debt/Capital46.4%
Gross Margin24.4%
EBIT/Int Exp5.6

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.